“EPIDEMIOLOGICAL INVESTIGATION AND CLINICAL MANAGEMENT FOR THE TREATMENT OF EPILEPSY” (2022) Journal of Pharmaceutical Negative Results, pp. 6432–6441. doi:10.47750/pnr.2022.13.S09.765.